Duration of Adalimumab Therapy in Hidradenitis Suppurativa With and Without Oral Immunosuppressants.

Micaella R Zubkov Reid A Waldman Rong Wu Jane M Grant-Kels

Cutis

Dr. Zubkov is from the University of Connecticut School of Medicine, Farmington. Drs. Waldman and Grant-Kels are from the Department of Dermatology, University of Connecticut Health Center, Farmington. Dr. Grant-Kels also is from the Department of Dermatology, University of Florida, Gainesville. Dr. Wu is from the Connecticut Convergence Institute for Translation in Regenerative Engineering, University of Connecticut, Farmington.

Published: October 2021

Download full-text PDF	Source
http://dx.doi.org/10.12788/cutis.0366	DOI Listing

Publication Analysis

Top Keywords

duration adalimumab

adalimumab therapy

therapy hidradenitis

hidradenitis suppurativa

suppurativa oral

oral immunosuppressants

duration

therapy

hidradenitis

suppurativa

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!